<DOC>
	<DOCNO>NCT00419913</DOCNO>
	<brief_summary>Our long term goal elucidate role DHEA follicular dynamic human ovary good understand interaction DHEA supplementation treatment ovulation induction , especially among old reproductive age woman . The specific hypothesis behind propose research DHEA regulator follicular dynamic act early pre-gonadotropin dependent stage initial primordial follicle recruitment growth .</brief_summary>
	<brief_title>A Trial Dehydroepiandrosterone ( DHEA ) Treatment Vitro Fertilization ( IVF )</brief_title>
	<detailed_description>Specific Aims : The ability woman respond ovulation inducing medication also call ovarian reserve , decline age . ( Navot , Bergh et al . 1991 ; Scott , Leonardi et al . 1993 ; Toner Flood 1993 ; Scott Hofmann 1995 ; Scott 1996 ; ASRM 2002 ) When attempt in-vitro fertilization ( IVF ) , old woman produce oocyte ( Chuang , Chen et al . 2003 ; Orvieto , Bar-Hava et al . 2004 ) yield normal embryo , even expose maximal gonadotropin stimulation . ( Orvieto , Bar-Hava et al . 2004 ) As result reproductive success woman 40 year old significantly reduce compare young woman . Older ovary antral follicle , high rate follicular degeneration ( atresia ) ( Faddy 2000 ) increase `` resistance '' ovulation induction . ( Filicori 1999 ; Chuang , Chen et al . 2003 ; Kupesic , Kurjak et al . 2003 ) A delay onset atresia could salvage follicle later ovulation . Our long term goal elucidate role DHEA follicular dynamic human ovary good understand interaction DHEA supplementation treatment ovulation induction , especially among old reproductive age woman . The specific hypothesis behind propose research DHEA regulator follicular dynamic act early pre-gonadotropin dependent stage initial primordial follicle recruitment growth . That hypothesis base following observation . First , physiological dos DHEA increase serum level insulin-like growth factor ( IGF-l ) . ( Casson , Santoro et al . 1998 ) DHEA produce ovarian theca , ( Burger 2002 ) increase concentration follicular DHEA associate increased aromatase activity , ( Franks , Mason et al . 2000 ) DHEA prohormone convert peripheral tissue estrogen . ( Haning , Hackett et al . 1993 ) Second , DHEA expose rat simulate polycystic ovary syndrome ( PCO ) ( Roy , Mahesh et al . 1962 ) high percentage meiotically active oocyte less evidence atresia . ( Anderson , Lee et al . 1997 ) Women chronically expose androgen develop PCO-like ovary . ( Amirikia , Savoy-Moore et al . 1986 ) Women anovulatory PCO less evidence follicle atresia . ( Franks , Mason et al . 2000 ) Third , Casson et al ( Casson , Lindsay et al . 2000 ) find small increase follicle number E2 response ovulation induction two month DHEA ( 80 mg/day ) administration five woman , proven ovarian resistance stimulation . Preliminary data Barad Gleicher report patient history severely decreased ovarian reserve dramatically increase oocyte production nine cycle treatment take DHEA ovulation induction . ( Barad Gleicher 2005 ) The dramatic increase oocyte production see patient occur four month DHEA treatment ( 75 mg/day ) . This treatment duration keep interval require normal follicular initiation recruitment growth ( Gougeon 1986 ) raise possibility Casson et al . treat subject long enough achieve maximum effect . Our case report follow case control study show increased oocyte production improve embryo quality among 25 DHEA treat patient , whose pre-treatment cycle act control . ( Barad Gleicher 2005 ) More recently show DHEA treat patient significant decreased ovarian reserve high pregnancy rate compare control . ( Barad , Brill et al . 2006 ) Based observation experimental focus project interaction DHEA adjuvant treatment gonadotropin treatment ovulation induction . The specific aim design provide comprehensive assessment effect . 1 . DHEA treatment increase pregnancy rate among woman 40 45 year old . 2 . DHEA treatment increase antral follicle count . 3 . DHEA lead increase anti-mullerian ( AMH ) hormone level . 4 . DHEA treatment increase mean peak follicular phase estradiol . 5 . DHEA treatment increase number oocytes retrieve IVF cycle compare placebo . Research Plan : Placebo control randomize trial 2 month DHEA pretreatment prior ovulation induction IVF-ET . Hypothesis 1 : Two month DHEA pretreatment improve chance pregnancy lead great oocyte embryo yield relative placebo treat control patient . Hypothesis 2 : Embryos produce follow 2 month pretreatment either DHEA alone OR DHEA plus supplemental FSH 150 unit per day result embryos good morphology Hypothesis 3a-c : Two month DHEA pretreatment result : ) increase antral follicle count , increase AMH , b ) increase mean peak estradiol c ) increase oocyte production Recruitment plan : - New patient present treatment . - Possible print , magazine Radio advertisement References : Amirikia , H. , R. T. Savoy-Moore , et al . ( 1986 ) . `` The effect long-term androgen treatment ovary . '' Fertil Steril 45 ( 2 ) : 202-8 . Anderson , E. , G. Y. Lee , et al . ( 1997 ) . `` Polycystic ovarian condition dehydroepiandrosterone-treated rat model : hyperandrogenism resumption meiosis major initial event associate cystogenesis antral follicle . '' Anat Rec 249 ( 1 ) : 44-53 . ASRM ( 2002 ) . `` Aging infertility woman : committee opinion . '' Fertil Steril 78 ( 1 ) : 215-9 . Barad , D. , H. Brill , et al . ( 2006 ) . `` Dehydroepiandrosterone ( DHEA ) Increases Pregnancy Rates Women Diminished Ovarian Reserve : A Case Controlled Study . '' Submitted Publication . Barad , D. N. Gleicher ( 2005 ) . `` Effect dehydroepiandrosterone ( DHEA ) oocyte embryo yield , embryo grade cell number IVF . '' Human Reproduction In Press . Barad , D. N. Gleicher ( 2005 ) . `` Increased Oocyte Production Treatment Dehydroepiandrosterone . '' Fertil Steril 84 ( 3 ) : 756 . Burger , H. G. ( 2002 ) . `` Androgen production woman . '' Fertil Steril 77 Suppl 4 : S3-5 . Casson , P. R. , M. S. Lindsay , et al . ( 2000 ) . `` Dehydroepiandrosterone supplementation augments ovarian stimulation poor responder : case series . '' Hum Reprod 15 ( 10 ) : 2129-32 . Casson , P. R. , N. Santoro , et al . ( 1998 ) . `` Postmenopausal dehydroepiandrosterone administration increase free insulin-like growth factor-I decrease high-density lipoprotein : six-month trial . '' Fertil Steril 70 ( 1 ) : 107-10 . Chuang , C. C. , C. D. Chen , et al . ( 2003 ) . `` Age well predictor pregnancy potential basal follicle-stimulating hormone level woman undergo vitro fertilization . '' Fertil Steril 79 ( 1 ) : 63-8 . Faddy , M. J . ( 2000 ) . `` Follicle dynamic ovarian ageing . '' Mol Cell Endocrinol 163 ( 1-2 ) : 43-8 . Filicori , M. ( 1999 ) . `` The role luteinizing hormone folliculogenesis ovulation induction . '' Fertil Steril 71 ( 3 ) : 405-14 . Franks , S. , H. Mason , et al . ( 2000 ) . `` Follicular dynamic polycystic ovary syndrome . '' Mol Cell Endocrinol 163 ( 1-2 ) : 49-52 . Gougeon , A . ( 1986 ) . `` Dynamics follicular growth human : model preliminary result . '' Hum Reprod 1 ( 2 ) : 81-7 . Haning , R. V. , Jr. , R. J. Hackett , et al . ( 1993 ) . `` Plasma dehydroepiandrosterone sulfate serve prehormone 48 % follicular fluid testosterone treatment menotropins . '' J Clin Endocrinol Metab 76 ( 5 ) : 1301-7 . Kupesic , S. , A. Kurjak , et al . ( 2003 ) . `` Three-dimensional ultrasonographic ovarian measurement vitro fertilization outcome relate age . '' Fertil Steril 79 ( 1 ) : 190-7 . Navot , D. , P. A. Bergh , et al . ( 1991 ) . `` Poor oocyte quality rather implantation failure cause age-related decline female fertility . '' Lancet 337 ( 8754 ) : 1375-7 . Orvieto , R. , I. Bar-Hava , et al . ( 2004 ) . `` Results vitro fertilization cycle woman age 43-45 year . '' Gynecol Endocrinol 18 ( 2 ) : 75-8 . Roy , S. , V. Mahesh , et al . ( 1962 ) . `` The effect dehydroepiandrosterone D4-androstenedione reproductive organ female rat : Production cystic change ovary . '' Nature 196 : 42-43 . Scott , R. T. , Jr. ( 1996 ) . `` Evaluation treatment low responder . '' Semin Reprod Endocrinol 14 ( 4 ) : 317-37 . Scott , R. T. , Jr. G. E. Hofmann ( 1995 ) . `` Prognostic assessment ovarian reserve . '' Fertil Steril 63 ( 1 ) : 1-11 . Scott , R. T. , M. R. Leonardi , et al . ( 1993 ) . `` A prospective evaluation clomiphene citrate challenge test screen general infertility population . '' Obstet Gynecol 82 ( 4 Pt 1 ) : 539-44 . Toner , J. P. J. T. Flood ( 1993 ) . `` Fertility age 40 . '' Obstet Gynecol Clin North Am 20 ( 2 ) : 261-72 .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Dehydroepiandrosterone</mesh_term>
	<criteria>Women age 40 less 45 year old presenting IVF treatment . Willingness sign inform consent study randomization . Willingness participate 2 month preIVF treatment . Medical condition would contraindicate pregnancy , ovulation induction general anesthesia . Family history significant genetic disease , factor V Leiden thrombophilia . Inability present monitoring visit . Inability follow medication instruction .</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2008</verification_date>
	<keyword>Ovulation Induction</keyword>
	<keyword>In vitro Fertilization</keyword>
	<keyword>Pregnancy</keyword>
</DOC>